Database Study to Provide Information on Pregnancy and Infant Outcomes Among Women Exposed to QUVIVIQ (Daridorexant)

Running, not enrolling

Conditions studied: Insomnia Disorder

In brief

Healthcare claims database study to provide safety information on maternal, fetal and infant outcomes among women exposed to QUVIVIQ (daridorexant) during pregnancy

Key facts

Study ID

NCT06393504

Run by

Idorsia Pharmaceuticals Ltd.

People needed

2095

Starts

2023-11-30

Expected to finish

2028-04-01

Last updated by the study team

2025-08-19

Who can join

Age: 15 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Carelon Research — Wilmington, Delaware, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.